Nautilus Biotechnology shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Nautilus Biotechnology
Tip: Access up to 7 years of quarterly data
All positions including Nautilus Biotechnology held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Nautilus Biotechnology by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8k | 2.1k | 0.84 |
| 2025-03-31 | $56k | 65k | 0.86 |
| 2024-12-31 | $245k | 146k | 1.68 |
| 2024-09-30 | $102k | 36k | 2.85 |
| 2024-06-30 | $88k | 38k | 2.34 |
| 2024-03-31 | $188k | 64k | 2.94 |
| 2023-12-31 | $181k | 61k | 2.99 |
| 2023-09-30 | $179k | 57k | 3.16 |
| 2023-06-30 | $165k | 43k | 3.87 |
| 2023-03-31 | $9.0k | 3.4k | 2.67 |
| 2022-12-31 | $54k | 30k | 1.82 |
| 2022-06-30 | $87k | 31k | 2.77 |
| 2022-03-31 | $64k | 15k | 4.33 |
| 2021-12-31 | $57k | 11k | 5.21 |